In June 2020, NPR analysis revealed that the federal government had awarded over 250 COVID-19 related contracts worth more than $1 million each without full competitive bidding, totaling billions of dollars in federal spending. Many contracts went to companies with no experience in medical …
Trump AdministrationFEMAU.S. Department of JusticeCongressional Oversightcovid-19corruptionprice-gouginghealthcareregulatory-capture+1 more
Valeant Pharmaceuticals’ October 2015 disclosure of its relationship with specialty pharmacy Philidor Rx Services triggered the unraveling of a systematic drug price gouging scheme that had raised prices on dozens of medications by 50-3000% over two years. Under CEO Michael Pearson, Valeant …
Valeant PharmaceuticalsJ. Michael PearsonPhilidor Rx ServicesWilliam AckmanSecurities and Exchange Commission (SEC)+2 morepharmaceutical-industrydrug-pricinghealthcarecorporate-fraudsystematic-corruption+1 more
Questcor Pharmaceuticals implemented an overnight price increase for H.P. Acthar Gel from $1,600 to $23,000 per vial on August 27, 2007, launching a decade-long price gouging scheme that would eventually raise the drug’s price by 97,000% from its 2001 level. Questcor had acquired Acthar—a …
Questcor PharmaceuticalsMallinckrodtFederal Trade CommissionHumanaCongress+1 morepharmaceutical-industrydrug-pricinghealthcarecorporate-fraudbribery+2 more